<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05064137</url>
  </required_header>
  <id_info>
    <org_study_id>257</org_study_id>
    <nct_id>NCT05064137</nct_id>
  </id_info>
  <brief_title>Comparative Evaluation of Self-assembling Peptide P11-4 Versus Tricalcium Phosphate Fluoride Varnish</brief_title>
  <official_title>Comparative Evaluation of Self-assembling Peptide P11-4 Versus Tricalcium Phosphate Fluoride Varnish in Remineralization of White Spot Lesions Among a Group of Egyptian Children : A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to evaluate the success of Self-assembling Peptide P11-4&#xD;
      versus Tricalcium Phosphate Fluoride Varnish in remineralization of WSLs in primary dentition&#xD;
      among a group of Egyptian children.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Double blinded ( participant and statistician )</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Remineralization of white spot lesions</measure>
    <time_frame>through study completion, an average of one year</time_frame>
    <description>Remineralization of white spot lesions evaluated by DIAGNOdent laser pen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Regression of caries</measure>
    <time_frame>through study completion, an average of one year</time_frame>
    <description>Regression of caries evaluated by International Caries Detection and Assessment System (ICDAS) II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inactivation of active carious lesions</measure>
    <time_frame>through study completion, an average of one year</time_frame>
    <description>Inactivation of active carious lesions evaluated by Lesion activity assessment (LAA-ICDAS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Remineralization</condition>
  <arm_group>
    <arm_group_label>Curodont Repair® ( monomeric self - assembling peptide P11-4 )</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Self assembling peptide P11-4 as Curodont Repair® can remineralize WSLs in a deeper manner than fluoride by guided enamel regeneration by forming a three-dimensional matrix within the subsurface body of an initial carious lesion to which calcium and phosphate ions found in natural saliva can bind and build de novo hydroxyapatite crystals.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinpro white varnish® ( Tricalcium Phosphate Fluoride Varnish, 5% F- )</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fluoride varnish is the gold standard for treating WSLs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Monomeric self - assembling peptide P11-4</intervention_name>
    <description>Monomeric self - assembling peptide P11-4 ( Curodont Repair ) is a remineralizing agent applied to tooth surface after treating it with 3% sodium hypochlorite for 20 seconds then etching it with 37% phosphoric acid for 20 seconds followed by rinsing then dryness.</description>
    <arm_group_label>Curodont Repair® ( monomeric self - assembling peptide P11-4 )</arm_group_label>
    <other_name>Curodont Repair</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tricalcium phosphate fluoride varnish, 5% F-</intervention_name>
    <description>Tricalcium phosphate fluoride varnish, 5% F- ( Clinpro White Varnish ) is a remineralizing agent applied on tooth surface after mixing it with a brush onto the dosage guide.</description>
    <arm_group_label>Clinpro white varnish® ( Tricalcium Phosphate Fluoride Varnish, 5% F- )</arm_group_label>
    <other_name>3M Clinpro white varnish</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Apparently healthy cooperative children&#xD;
&#xD;
          -  Aging from 3-8 years old child&#xD;
&#xD;
          -  Both genders&#xD;
&#xD;
          -  Primary teeth with active WSLs on buccal or labial surfaces&#xD;
&#xD;
          -  Patient and parent acceptance to treatment and maintenance of good oral hygiene&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Restored teeth&#xD;
&#xD;
          -  White spot lesions due to fluorosis&#xD;
&#xD;
          -  Teeth with hypoplasia&#xD;
&#xD;
          -  Lesions that require an invasive treatment&#xD;
&#xD;
          -  Any pathology or concomitant medication affecting salivary flow or causing dry mouth&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yara A Abdellatif, BDS</last_name>
    <phone>00201007627551</phone>
    <email>yaraabdellatif@dentistry.cu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rasha Hatem, PHD</last_name>
  </overall_contact_backup>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 18, 2021</study_first_submitted>
  <study_first_submitted_qc>September 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2021</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Yara Ahmed Ibrahim Abdellatif</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Listerine</mesh_term>
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Fluorides, Topical</mesh_term>
    <mesh_term>Sodium Fluoride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

